Grubor, Nikica

Link to this page

Authority KeyName Variants
cb83e897-2262-4f35-a6da-ad2d74068f75
  • Grubor, Nikica (3)
Projects
No records found.

Author's Bibliography

Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?

Manić, Luka; Đorđević, Vladimir; Grubor, Nikica; Bulat, Zorica; Antonijević, Biljana; Đukić-Ćosić, Danijela; Uysal-Onganer, Pinar; Mortoglou, Maria; Wallace, David; Buha-Đorđević, Aleksandra

(Udruženje toksikologa Srbije, 2023)

TY  - CONF
AU  - Manić, Luka
AU  - Đorđević, Vladimir
AU  - Grubor, Nikica
AU  - Bulat, Zorica
AU  - Antonijević, Biljana
AU  - Đukić-Ćosić, Danijela
AU  - Uysal-Onganer, Pinar
AU  - Mortoglou, Maria
AU  - Wallace, David
AU  - Buha-Đorđević, Aleksandra
PY  - 2023
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/5512
AB  - Istraživanje u oblasti karcinoma pankreasa i zagađivača iz životne sredine sve je intenzivnije. Za neke od ovih zagađivača pretpostavlja se da su povezani sa nastankom ili progresijom karcinoma pankreasa. Nijedna meta-analiza o povezanosti navedenog nije sprovedena, dok bi rezultati iste mogli pomoći u tumačenju dostupnih podataka i usmeravanju budućeg istraživanja. ...
AB  - There is a rise in research on the connection between pancreatic cancer and environmental pollutants. Some of these pollutants are assumed to be associated with the onset or progression of pancreatic cancer. No meta-analyses summarizing the association between these two have been conducted yet, while the results of such an analysis could help interpret current and guide future research.  ...
PB  - Udruženje toksikologa Srbije
C3  - 13th international congress of the Serbian society of toxicology & 1st toxSEE regional conference, 10-12 May, 2023, Belgrade, Abstract Book
T1  - Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?
T1  - A meta-analysis excerpt: Is exposure to environmental pollutants associated with pancreatic cancer?
SP  - 143
EP  - 146
UR  - https://hdl.handle.net/21.15107/rcub_farfar_5512
ER  - 
@conference{
author = "Manić, Luka and Đorđević, Vladimir and Grubor, Nikica and Bulat, Zorica and Antonijević, Biljana and Đukić-Ćosić, Danijela and Uysal-Onganer, Pinar and Mortoglou, Maria and Wallace, David and Buha-Đorđević, Aleksandra",
year = "2023",
abstract = "Istraživanje u oblasti karcinoma pankreasa i zagađivača iz životne sredine sve je intenzivnije. Za neke od ovih zagađivača pretpostavlja se da su povezani sa nastankom ili progresijom karcinoma pankreasa. Nijedna meta-analiza o povezanosti navedenog nije sprovedena, dok bi rezultati iste mogli pomoći u tumačenju dostupnih podataka i usmeravanju budućeg istraživanja. ..., There is a rise in research on the connection between pancreatic cancer and environmental pollutants. Some of these pollutants are assumed to be associated with the onset or progression of pancreatic cancer. No meta-analyses summarizing the association between these two have been conducted yet, while the results of such an analysis could help interpret current and guide future research.  ...",
publisher = "Udruženje toksikologa Srbije",
journal = "13th international congress of the Serbian society of toxicology & 1st toxSEE regional conference, 10-12 May, 2023, Belgrade, Abstract Book",
title = "Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?, A meta-analysis excerpt: Is exposure to environmental pollutants associated with pancreatic cancer?",
pages = "143-146",
url = "https://hdl.handle.net/21.15107/rcub_farfar_5512"
}
Manić, L., Đorđević, V., Grubor, N., Bulat, Z., Antonijević, B., Đukić-Ćosić, D., Uysal-Onganer, P., Mortoglou, M., Wallace, D.,& Buha-Đorđević, A.. (2023). Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?. in 13th international congress of the Serbian society of toxicology & 1st toxSEE regional conference, 10-12 May, 2023, Belgrade, Abstract Book
Udruženje toksikologa Srbije., 143-146.
https://hdl.handle.net/21.15107/rcub_farfar_5512
Manić L, Đorđević V, Grubor N, Bulat Z, Antonijević B, Đukić-Ćosić D, Uysal-Onganer P, Mortoglou M, Wallace D, Buha-Đorđević A. Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?. in 13th international congress of the Serbian society of toxicology & 1st toxSEE regional conference, 10-12 May, 2023, Belgrade, Abstract Book. 2023;:143-146.
https://hdl.handle.net/21.15107/rcub_farfar_5512 .
Manić, Luka, Đorđević, Vladimir, Grubor, Nikica, Bulat, Zorica, Antonijević, Biljana, Đukić-Ćosić, Danijela, Uysal-Onganer, Pinar, Mortoglou, Maria, Wallace, David, Buha-Đorđević, Aleksandra, "Odlomak iz meta-analize: Da li je izloženost zagađivačima iz životne sredine povezana sa karcinomom pankreasa?" in 13th international congress of the Serbian society of toxicology & 1st toxSEE regional conference, 10-12 May, 2023, Belgrade, Abstract Book (2023):143-146,
https://hdl.handle.net/21.15107/rcub_farfar_5512 .

Cadmium in human pancreatic cancer - preliminary report

Đorđević, Vladimir; Knežević, D.; Matić, S.; Kerkez, Mirko; Zarić, N.; Grubor, Nikica; Bidzić, N.; Boricić, Novica; Boricić, I.; Matović, Vesna; Buha, Aleksandra

(Elsevier Ireland Ltd, Clare, 2016)

TY  - CONF
AU  - Đorđević, Vladimir
AU  - Knežević, D.
AU  - Matić, S.
AU  - Kerkez, Mirko
AU  - Zarić, N.
AU  - Grubor, Nikica
AU  - Bidzić, N.
AU  - Boricić, Novica
AU  - Boricić, I.
AU  - Matović, Vesna
AU  - Buha, Aleksandra
PY  - 2016
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2666
PB  - Elsevier Ireland Ltd, Clare
C3  - Toxicology Letters
T1  - Cadmium in human pancreatic cancer - preliminary report
VL  - 258
IS  - Supplement
SP  - S92
EP  - S93
DO  - 10.1016/j.toxlet.2016.06.1406
ER  - 
@conference{
author = "Đorđević, Vladimir and Knežević, D. and Matić, S. and Kerkez, Mirko and Zarić, N. and Grubor, Nikica and Bidzić, N. and Boricić, Novica and Boricić, I. and Matović, Vesna and Buha, Aleksandra",
year = "2016",
publisher = "Elsevier Ireland Ltd, Clare",
journal = "Toxicology Letters",
title = "Cadmium in human pancreatic cancer - preliminary report",
volume = "258",
number = "Supplement",
pages = "S92-S93",
doi = "10.1016/j.toxlet.2016.06.1406"
}
Đorđević, V., Knežević, D., Matić, S., Kerkez, M., Zarić, N., Grubor, N., Bidzić, N., Boricić, N., Boricić, I., Matović, V.,& Buha, A.. (2016). Cadmium in human pancreatic cancer - preliminary report. in Toxicology Letters
Elsevier Ireland Ltd, Clare., 258(Supplement), S92-S93.
https://doi.org/10.1016/j.toxlet.2016.06.1406
Đorđević V, Knežević D, Matić S, Kerkez M, Zarić N, Grubor N, Bidzić N, Boricić N, Boricić I, Matović V, Buha A. Cadmium in human pancreatic cancer - preliminary report. in Toxicology Letters. 2016;258(Supplement):S92-S93.
doi:10.1016/j.toxlet.2016.06.1406 .
Đorđević, Vladimir, Knežević, D., Matić, S., Kerkez, Mirko, Zarić, N., Grubor, Nikica, Bidzić, N., Boricić, Novica, Boricić, I., Matović, Vesna, Buha, Aleksandra, "Cadmium in human pancreatic cancer - preliminary report" in Toxicology Letters, 258, no. Supplement (2016):S92-S93,
https://doi.org/10.1016/j.toxlet.2016.06.1406 . .
1
1

Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis

Vucelić, Dragica; Jesić, Rada; Jovičić, Snežana; Zivotić, Maja; Grubor, Nikica; Trajković, Goran; Canić, Ivana; Elezović, Ivo; Antović, Aleksandra

(Pergamon-Elsevier Science Ltd, Oxford, 2015)

TY  - JOUR
AU  - Vucelić, Dragica
AU  - Jesić, Rada
AU  - Jovičić, Snežana
AU  - Zivotić, Maja
AU  - Grubor, Nikica
AU  - Trajković, Goran
AU  - Canić, Ivana
AU  - Elezović, Ivo
AU  - Antović, Aleksandra
PY  - 2015
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2396
AB  - Background: The Clauss fibrinogen method and thrombin clotting time (TCT) are still routinely used in patients with cirrhosis to define fibrinogen concentration and clotting potential. The thromboelastometric functional fibrinogen FIBTEM assay evaluates the strength of fibrin-based clots in whole blood, providing information on both quantitative deficit and fibrin polymerization disorders. Objective: To compare these three methods of assessing fibrinogen in patients with cirrhosis of different aetiologies, characterized by impairment in fibrinogen concentration as well as functional aberrance. Methods: Sixty patients with alcoholic and 24 patients with cholestatic cirrhosis were included (Child-Pugh score (CPs) A, n = 24; B, n = 32; C, n = 28). All parameters were compared with those from a control group. Maximum clot firmness (MCF) in the FIBTEM test was assessed in regard to its relevance in detection of qualitative fibrinogen disorders in comparison with results obtained by standard measurement methods, i.e. the Clauss fibrinogen method and TCT. Results: With increased cirrhosis severity, fibrinogen and FIBTEM-MCF levels significantly declined (p = 0.002), while TCT was significantly prolonged (p = 0.002). In all CPs groups, fibrinogen strongly correlated with FIBTEM-MCF (r = 0.77, r = 0.72, r = 0.74; p  lt  0.001), while cross-correlations of other assays were highly variable. The prevalence of decreased FIBTEM-MCF values ( lt 9 mm) was significantly higher in advanced CPs categories (p = 0.027), whereby the highest prevalence was detected in patients with CPsC (10/16; 62.5%). Nine of the 16 patients with decreased FIBTEM-MCF values had also decreased fibrinogen levels, while in the remaining 7 patients fibrinogen levels were within the reference range, indicating the possible presence of qualitatively altered fibrinogen that could be detected by FIBTEM-MCF. Conclusions: FIBTEM-MCF may be considered as a reliable alternative to standard plasma fibrinogen measurement in cirrhotic patients, especially in evaluating fibrin polymerization disorders in these patients. Further studies are needed to evaluate the usefulness of this assay in predicting bleeding complications in cirrhotic patients as well as monitoring replacement treatment.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Tohoku Journal of Experimental Medicine
T1  - Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis
VL  - 135
IS  - 6
SP  - 1124
EP  - 1130
DO  - 10.1016/j.thromres.2015.04.003
ER  - 
@article{
author = "Vucelić, Dragica and Jesić, Rada and Jovičić, Snežana and Zivotić, Maja and Grubor, Nikica and Trajković, Goran and Canić, Ivana and Elezović, Ivo and Antović, Aleksandra",
year = "2015",
abstract = "Background: The Clauss fibrinogen method and thrombin clotting time (TCT) are still routinely used in patients with cirrhosis to define fibrinogen concentration and clotting potential. The thromboelastometric functional fibrinogen FIBTEM assay evaluates the strength of fibrin-based clots in whole blood, providing information on both quantitative deficit and fibrin polymerization disorders. Objective: To compare these three methods of assessing fibrinogen in patients with cirrhosis of different aetiologies, characterized by impairment in fibrinogen concentration as well as functional aberrance. Methods: Sixty patients with alcoholic and 24 patients with cholestatic cirrhosis were included (Child-Pugh score (CPs) A, n = 24; B, n = 32; C, n = 28). All parameters were compared with those from a control group. Maximum clot firmness (MCF) in the FIBTEM test was assessed in regard to its relevance in detection of qualitative fibrinogen disorders in comparison with results obtained by standard measurement methods, i.e. the Clauss fibrinogen method and TCT. Results: With increased cirrhosis severity, fibrinogen and FIBTEM-MCF levels significantly declined (p = 0.002), while TCT was significantly prolonged (p = 0.002). In all CPs groups, fibrinogen strongly correlated with FIBTEM-MCF (r = 0.77, r = 0.72, r = 0.74; p  lt  0.001), while cross-correlations of other assays were highly variable. The prevalence of decreased FIBTEM-MCF values ( lt 9 mm) was significantly higher in advanced CPs categories (p = 0.027), whereby the highest prevalence was detected in patients with CPsC (10/16; 62.5%). Nine of the 16 patients with decreased FIBTEM-MCF values had also decreased fibrinogen levels, while in the remaining 7 patients fibrinogen levels were within the reference range, indicating the possible presence of qualitatively altered fibrinogen that could be detected by FIBTEM-MCF. Conclusions: FIBTEM-MCF may be considered as a reliable alternative to standard plasma fibrinogen measurement in cirrhotic patients, especially in evaluating fibrin polymerization disorders in these patients. Further studies are needed to evaluate the usefulness of this assay in predicting bleeding complications in cirrhotic patients as well as monitoring replacement treatment.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Tohoku Journal of Experimental Medicine",
title = "Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis",
volume = "135",
number = "6",
pages = "1124-1130",
doi = "10.1016/j.thromres.2015.04.003"
}
Vucelić, D., Jesić, R., Jovičić, S., Zivotić, M., Grubor, N., Trajković, G., Canić, I., Elezović, I.,& Antović, A.. (2015). Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis. in Tohoku Journal of Experimental Medicine
Pergamon-Elsevier Science Ltd, Oxford., 135(6), 1124-1130.
https://doi.org/10.1016/j.thromres.2015.04.003
Vucelić D, Jesić R, Jovičić S, Zivotić M, Grubor N, Trajković G, Canić I, Elezović I, Antović A. Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis. in Tohoku Journal of Experimental Medicine. 2015;135(6):1124-1130.
doi:10.1016/j.thromres.2015.04.003 .
Vucelić, Dragica, Jesić, Rada, Jovičić, Snežana, Zivotić, Maja, Grubor, Nikica, Trajković, Goran, Canić, Ivana, Elezović, Ivo, Antović, Aleksandra, "Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis" in Tohoku Journal of Experimental Medicine, 135, no. 6 (2015):1124-1130,
https://doi.org/10.1016/j.thromres.2015.04.003 . .
16
10
14